MRI-Guided Diffuse Optical Spectroscopy of Malignant and Benign Breast Lesions

by Vasilis Ntziachristos, A.G. Yodh, Mitchell D. Schnall, Britton Chance
Published 2002-01-01

Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection

by Puneet Bagga, Mohammad Haris, Kevin D’Aquilla, Neil E. Wilson, Francesco M. Marincola, Mitchell D. Schnall, Hari Hariharan, Ravinder Reddy
Published 2017-05-01

Optically measured microvascular blood flow contrast of malignant breast tumors.

by Regine Choe, Mary E Putt, Peter M Carlile, Turgut Durduran, Joseph M Giammarco, David R Busch, Ki Won Jung, Brian J Czerniecki, Julia Tchou, Michael D Feldman, Carolyn Mies, Mark A Rosen, Mitchell D Schnall, Angela DeMichele, Arjun G Yodh
Published 2014-01-01

Future vision for the quality assurance of oncology clinical trials

by Thomas eFitzGerald, MD, Thomas eFitzGerald, MD, Maryann eBishop-Jodoin, BS, Walter eBosch, DSc, Walter J. Curran, MD, David eFollowill, PhD, James M. Galvin, DSc, James M. Galvin, DSc, Richard eHanusik, AB, Steven R. King, MS, Michael V Knopp, MD, PhD, Fran eLaurie, BS, Elizabeth eO'Meara, BS, RT(R)(T), Jeff M. Michalski, MD, MBA, Joel H. Saltz, MD, PhD, Mitchell D. Schnall, MD, PhD, Lawrence eSchwartz, MD, Kenneth eUlin, PhD, Kenneth eUlin, PhD, Ying eXiao, PhD, Ying eXiao, PhD, Marcia M. Urie, PhD
Published 2013-03-01